Correlation Between AVRO Old and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both AVRO Old and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVRO Old and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVRO Old and Sana Biotechnology, you can compare the effects of market volatilities on AVRO Old and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVRO Old with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVRO Old and Sana Biotechnology.
Diversification Opportunities for AVRO Old and Sana Biotechnology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between AVRO and Sana is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AVRO Old and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and AVRO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVRO Old are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of AVRO Old i.e., AVRO Old and Sana Biotechnology go up and down completely randomly.
Pair Corralation between AVRO Old and Sana Biotechnology
If you would invest 161.00 in Sana Biotechnology on December 27, 2024 and sell it today you would earn a total of 24.00 from holding Sana Biotechnology or generate 14.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
AVRO Old vs. Sana Biotechnology
Performance |
Timeline |
AVRO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Sana Biotechnology |
AVRO Old and Sana Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AVRO Old and Sana Biotechnology
The main advantage of trading using opposite AVRO Old and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVRO Old position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.AVRO Old vs. Ocean Biomedical | AVRO Old vs. Enveric Biosciences | AVRO Old vs. Elevation Oncology | AVRO Old vs. Zura Bio Limited |
Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |